Drug comparisons
Insulin Regular Human vs Repaglinide
Compare regular insulin vs repaglinide for type 2 diabetes. Insulin is injectable short-acting, repaglinide is oral meglitinide stimulating insulin release.
No comparison dimensions are available for this page.
Clinical context
This comparison arises for type 2 diabetes patients considering meglitinide therapy versus starting insulin.
Bottom line
Insulin is more versatile and preferred for broader use while repaglinide offers convenient oral dosing with meal-related action.
All medication comparisons